Avicanna.png
Avicanna Announces Management Change
November 05, 2021 19:19 ET | Avicanna Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
Avicanna.png
Avicanna´s subsidiary obtains Good Agricultural and Collection Practices (“GACP”) Certification in Colombia
November 04, 2021 07:30 ET | Avicanna Inc.
The certification will allow the Company’s Aureus-branded raw material business with sales in 11 countries to include low cost and sustainable cannabis biomass for sale and export to the global...
Avicanna.png
Avicanna Completes Commercial Export of CBD Isolate and CBD Full Spectrum Psychoactive Derivatives from Colombia to Chile
October 22, 2021 07:30 ET | Avicanna Inc.
The Cannabis Derivatives are derived from Avicanna’s cultivation and extraction infrastructure in Santa Marta, Colombia designed to supply partner companies and the manufacture of Avicanna’s own...
Avicanna.png
Avicanna Closes Non-Brokered Private Placement Raising $3.9 Million and Announces Warrant Repricing
October 19, 2021 17:15 ET | Avicanna Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
211001 AVCN NR Image 1
Avicanna Completes First Commercial Export of Feminized Cannabis Seeds from Colombia to Peru and Argentina
October 01, 2021 07:30 ET | Avicanna Inc.
This marks Avicanna’s first commercial exports of proprietary genetics in the form of feminized seeds into the Peruvian and the Argentine medical cannabis markets.Avicanna worked closely with the...
Avicanna.png
Avicanna Files US Patent Application for a Novel Cannabinoid Formulation in Reducing Incidence of Seizures and Sudden Unexpected Death in Epilepsy
September 24, 2021 07:30 ET | Avicanna Inc.
Research findings originated from cannabinoid-based collaboration with leading epilepsy researcher, Dr. Peter Carlen, at UHN that is also supported by a Mitacs Accelerate program grant.Avicanna’s...
Avicanna.png
Avicanna Completes Registration and Commercial Export of its Evidence-Based CBD Dermacosmetics Brand, Pura Earth, in Ecuador
September 16, 2021 07:30 ET | Avicanna Inc.
Four SKUs of Pura Earth branded dermacosmetics have been successfully registered with ARCSA, imported into Ecuador, and will be distributed and commercialized through previously announced partnership...
Avicanna.png
Avicanna Announces Revocation of Cease Trade Order
September 13, 2021 07:30 ET | Avicanna Inc.
TORONTO, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing...
Avicanna.png
Avicanna Announces Filing of Interim Financial Statements for Period Ended June 30, 2021 and Provides Corporate Update
September 10, 2021 07:30 ET | Avicanna Inc.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
Avicanna.png
Avicanna Announces Filing of Interim Financial Statements For Three Month Period Ended March 31, 2021
September 07, 2021 22:50 ET | Avicanna Inc.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...